OncoCyte ROA 2014-2024 | OCX
Current and historical return on assets (ROA) values for OncoCyte (OCX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| OncoCyte ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-09-30 | $-0.04B | $0.07B | -60.48% |
| 2024-06-30 | $-0.04B | $0.08B | -50.17% |
| 2024-03-31 | $-0.04B | $0.07B | -51.90% |
| 2023-12-31 | $-0.03B | $0.08B | -35.37% |
| 2023-09-30 | $-0.06B | $0.08B | -64.59% |
| 2023-06-30 | $-0.06B | $0.09B | -56.07% |
| 2023-03-31 | $-0.06B | $0.08B | -46.97% |
| 2022-12-31 | $-0.07B | $0.10B | -50.87% |
| 2022-09-30 | $-0.06B | $0.16B | -40.38% |
| 2022-06-30 | $-0.07B | $0.17B | -42.17% |
| 2022-03-31 | $-0.07B | $0.15B | -43.01% |
| 2021-12-31 | $-0.06B | $0.16B | -40.38% |
| 2021-09-30 | $-0.03B | $0.17B | -25.71% |
| 2021-06-30 | $-0.03B | $0.18B | -25.78% |
| 2021-03-31 | $-0.03B | $0.13B | -34.10% |
| 2020-12-31 | $-0.03B | $0.06B | -50.85% |
| 2020-09-30 | $-0.03B | $0.06B | -57.92% |
| 2020-06-30 | $-0.03B | $0.06B | -61.22% |
| 2020-03-31 | $-0.03B | $0.06B | -60.82% |
| 2019-12-31 | $-0.02B | $0.04B | -57.52% |
| 2019-09-30 | $-0.02B | $0.03B | -61.79% |
| 2019-06-30 | $-0.02B | $0.04B | -66.02% |
| 2019-03-31 | $-0.02B | $0.04B | -88.31% |
| 2018-12-31 | $-0.02B | $0.01B | -133.33% |
| 2018-09-30 | $-0.02B | $0.01B | -125.49% |
| 2018-06-30 | $-0.02B | $0.01B | -153.85% |
| 2018-03-31 | $-0.02B | $0.02B | -146.15% |
| 2017-12-31 | $-0.02B | $0.01B | -156.86% |
| 2017-09-30 | $-0.02B | $0.01B | -138.18% |
| 2017-06-30 | $-0.02B | $0.01B | -103.45% |
| 2017-03-31 | $-0.01B | $0.02B | -105.66% |
| 2016-12-31 | $-0.01B | $0.01B | -100.00% |
| 2016-09-30 | $-0.01B | $0.02B | -110.64% |
| 2016-06-30 | $-0.01B | $0.01B | -160.00% |
| 2016-03-31 | $-0.01B | $0.01B | -173.91% |
| 2015-12-31 | $-0.01B | $0.01B | -246.15% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.047B | $0.002B |
| OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.197B | 27.76 |
| Elevance Health (ELV) | United States | $90.566B | 11.84 |
| CVS Health (CVS) | United States | $82.065B | 12.01 |
| Cencora (COR) | United States | $47.211B | 17.13 |
| DiDi Global (DIDIY) | China | $23.282B | 0.00 |
| Natera (NTRA) | United States | $22.205B | 0.00 |
| ICON (ICLR) | Ireland | $16.651B | 14.81 |
| BioMerieux (BMXMF) | France | $14.074B | 0.00 |
| Doximity (DOCS) | United States | $14.002B | 72.82 |
| Revvity (RVTY) | United States | $13.962B | 23.41 |
| Viatris (VTRS) | United States | $13.201B | 4.07 |
| Solventum (SOLV) | United States | $12.870B | 0.00 |
| Avantor (AVTR) | United States | $11.909B | 17.49 |
| CochLear (CHEOY) | Australia | $11.330B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.506B | 27.30 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.794B | 0.00 |
| HealthEquity (HQY) | United States | $9.682B | 48.57 |
| Sonic Healthcare (SKHHY) | Australia | $8.686B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.297B | 15.72 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.601B | 25.63 |
| Organon (OGN) | United States | $4.041B | 4.12 |
| Sotera Health (SHC) | United States | $3.829B | 20.49 |
| BrightSpring Health Services (BTSG) | United States | $3.552B | 75.56 |
| Surgery Partners (SGRY) | United States | $3.263B | 37.20 |
| Concentras Parent (CON) | United States | $2.981B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.791B | 338.60 |
| Alignment Healthcare (ALHC) | United States | $2.755B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.185B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.118B | 0.00 |
| Progyny (PGNY) | United States | $2.033B | 41.17 |
| PACS (PACS) | United States | $2.010B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.852B | 48.60 |
| Premier (PINC) | United States | $1.726B | 11.05 |
| Agilon Health (AGL) | United States | $1.492B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.480B | 12.40 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| CareDx (CDNA) | United States | $1.254B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.984B | 7.81 |
| Establishment Labs Holdings (ESTA) | $0.981B | 0.00 | |
| Embecta (EMBC) | United States | $0.838B | 5.74 |
| Auna S.A (AUNA) | Luxembourg | $0.611B | 0.00 |
| DocGo (DCGO) | United States | $0.513B | 19.35 |
| SBC Medicals (SBC) | United States | $0.483B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.480B | 0.00 |
| MultiPlan (MPLN) | United States | $0.477B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.453B | 0.00 |
| Enhabit (EHAB) | United States | $0.424B | 36.70 |
| Nutex Health (NUTX) | United States | $0.335B | 0.00 |
| LifeMD (LFMD) | United States | $0.326B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.311B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.294B | 7.71 |
| Beauty Health (SKIN) | United States | $0.199B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.183B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.144B | 0.00 |
| Biodesix (BDSX) | United States | $0.134B | 0.00 |
| So-Young (SY) | China | $0.114B | 19.40 |
| IceCure Medical (ICCM) | Israel | $0.083B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| ModivCare (MODV) | United States | $0.079B | 4.29 |
| Oncology Institute (TOI) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.62 |
| Singular Genomics Systems (OMIC) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.019B | 0.00 |
| KindlyMD (KDLY) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |